MSU drug developers win seed funding for development of cancer, tuberculosis drugs

Two biomedical researchers at MSU have received a total of $600,000 in high-risk, high-reward Catalyst Awards from the Dr. Ralph and Marian Falk Medical Research Trust.

Related Keywords

Michigan State University ,Michigan ,United States ,American ,Karen Liby ,Akeila Bio ,Matt Giletto ,Angela Wilson ,Johna Hannah ,Teresa Krieger Burke ,Robert Abramovitch ,Edmund Ellsworth ,Richard Neubig ,College Of Natural Science ,Innovation Center ,College Of Osteopathic Medicine ,Marian Falk Medical Research ,Michigan Translational Research ,Department Of Pharmacology ,American Chemical Society ,Abramovitch Laboratory ,College Of Osteopathic Medicine Applied Immunology Center ,Liby Lab ,Catalyst Awards ,Osteopathic Medicine ,Human Medicine ,Veterinary Medicine ,Transformational Award ,Medicinal Chemistry Facility ,Ana Mendes Leal ,Discovery Grant ,Innovation Hub ,Kickstart Award ,Commercialization Innovation Hub ,Applied Immunology Center ,Distinguished Professor ,Strategic Initiatives ,Natural Science ,Quantum Computing ,